In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds

158Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The in vitro activity of the new antifungal drug pneumocandin L-743,872 against 55 isolates of clinically important molds was examined by an adapted macrobroth dilution method for yeasts. Pneumocandin L-743,872 exhibited in vitro antifungal activity against Alternaria sp., Aspergillus flavus, Aspergillus fumigatus, Curvularia lunata, Exophiala jeanselmei, Fonsecaea pedrosoi, Paecilomyces variotii, and Scedosporium apiospermum. The drug appeared to lack significant in vitro inhibitory activity against Fusarium oxysporum, Fusarium solani, Rhizopus arrhizus, Paecilomyces lilacinus, and Scedosporium prolificans.

Cite

CITATION STYLE

APA

Del Poeta, M., Schell, W. A., & Perfect, J. R. (1997). In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrobial Agents and Chemotherapy, 41(8), 1835–1836. https://doi.org/10.1128/aac.41.8.1835

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free